Bioventus Inc. — Director's Dealing 2021

Feb 12, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Bioventus Inc. (BVS)
CIK: 0001665988
Period of Report: 2021-02-11

Reporting Person: SMITH & NEPHEW PLC (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Class A Common Stock	5428680	Indirect
Class B Common Stock	16534814	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Common LLC Units	$		Class A Common Stock (16534814)		Indirect

Footnotes

F1: Represents shares of Class A Common Stock of the Issuer ("Class A Shares") held by Smith & Nephew (Europe) B.V., a wholly owned, indirect subsidiary of the Reporting Person.

F2: Represents shares of Class B Common Stock of the Issuer ("Class B Shares") held by Smith & Nephew, Inc., a wholly owned, indirect subsidiary of the Reporting Person.

F3: Represents Common LLC Units of Bioventus LLC, a direct subsidiary of the Issuer, held by Smith & Nephew, Inc. The Common LLC Units are redeemable at the election of the Reporting Person at any time for newly-issued Class A Shares on a one-for-one basis or, if mutually agreed with the Issuer, a cash payment equal to the volume weighted average market price of one Class A Share for each Common LLC Unit redeemed (subject to customary adjustments, including for stock splits, stock dividends and reclassifications). However, the Issuer may elect to effect a direct exchange of such Class A Shares (or such cash, if mutually agreed) for such Common LLC Units.

F4: Upon the redemption by the Reporting Person of any Common LLC Units, a number of Class B Shares held by the Reporting Person equal to the number of Common LLC Units that are redeemed or exchanged will be automatically cancelled by the Issuer for no consideration.

F5: The Common LLC Units may be redeemed by the Reporting Person at any time on or following the Issuer's initial public offering.